Actions

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
JHS Svendgaard Laboratories Ltd (JHS) is currently trading at 8.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
JHS Svendgaard Laboratories Limited is a leading manufacturer of a comprehensive range of oral care products, including toothbrushes, toothpaste, and mouthwash. The company operates advanced manufacturing facilities in Himachal Pradesh and caters to various esteemed brands, including Amway, Dabur, and Hindustan Unilever. They have significantly expanded their production capacity over the years, increasing from 1.50 crore pieces to 24.62 crore pieces between 2006 and 2009. JHS Svendgaard has a history of strategic acquisitions and expansions, including the acquisition of Nikiven Personal Care Products, and the establishment of a subsidiary in the UAE. The company launched its own brand, 'Dr. Gold', to leverage its expertise in the oral care market, further establishing its presence in the sector.
Over the past 52 weeks, JHS Svendgaard Laboratories Ltd has traded between a low of ₹6.15 and a high of ₹13.83. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
JHS Svendgaard Laboratories Ltd has a market capitalization of approximately 79.80. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
JHS Svendgaard Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -42.22 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 79.80 Cr, JHS Svendgaard Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
JHS Svendgaard Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of JHS Svendgaard Laboratories Ltd is -42.22. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
2
Neutral
7
Bullish
5
Bearish
4
Neutral
7
Bullish
35
Bearish
2
Neutral
0
Bullish
30
Bearish
2
Neutral
7
Bullish
5
Bearish
2
Neutral
7
Bullish
5
Bearish
2
Neutral
0
Bullish
30
Bearish
2
Neutral
0
Bullish
30
Bearish
2
Neutral
0
Bullish
30
Personal Products
Personal Care
80 Cr
High Risk
-42.2
41.9
—
0.5
13.83
6.15
Sales CAGR
Profit CAGR
ROE
ROCE
